GlassScriptPhysician profile
Heather N Hamilton
NPI 1265705404
$9,999.22
in general payments reported to CMS, 2019-2025
51 companies · $1,659 in 2025
The $1,659 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,788 · 2022: $2,090 · 2023: $1,743 · 2024: $1,719 · 2025: $1,659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,036 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,036.13 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,342.51 | 2021-2025 | |
| Novo Nordisk INC | $1,445.77 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $563.48 | 2021-2025 | Mounjaro, Emgality, Jardiance |
| Glaxosmithkline, LLC. | $553.78 | 2021-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Astellas Pharma US INC | $550.46 | 2021-2024 | Veozah |
| Astrazeneca Pharmaceuticals LP | $465.81 | 2021-2025 | Airsupra, Farxiga |
| Amgen INC. | $435.86 | 2021-2025 | Otezla, Repatha, Repatha |
| Pfizer INC. | $364.16 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $298.84 | 2021-2025 | Eliquis |
| Janssen Pharmaceuticals, INC | $252.00 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.40 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $233.38 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $228.28 | 2021-2024 | |
| Abbott Laboratories | $196.31 | 2021-2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $158.94 | 2021-2022 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.